title: [Asthenic disorders in children].
abstract: The present study comprised two parts. In the first part, authors attempted to work out the systematics of asthenic disorders based on our own observations of 189 children aged 7-14 years. The following clinical variants of asthenic states in children were singled out: cerebrogenic asthenia (14.3%), somatogenic (13.8%), residual (16.4%), dysontogenetic (20.1%) and neurasthenia (35.4%). In the second part, we summarized the results of treatment of neurasthenia with adaptol (32 patients) compared to pantoham (30 patients). The efficacy of adaptol was higher: the improvement was seen in 71.9% of cases compared to pantoham (56.7%). The good tolerability of adaptol which clinical efficacy is confirmed by neurophysiological and psychological studies is discussed.
authors.forename: L S
authors.initials: LS
authors.lastname: Chutko
authors.forename: S Iu
authors.initials: SIu
authors.lastname: Surushkina
authors.forename: I S
authors.initials: IS
authors.lastname: Nikishena
authors.forename: E A
authors.initials: EA
authors.lastname: Iakovenko
authors.forename: T I
authors.initials: TI
authors.lastname: Anisimova
authors.forename: M P
authors.initials: MP
authors.lastname: Kuzovenkova
mesh_terms: D000293:Adolescent; D001247:Asthenia / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy*; D001736:Biureas / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D009440:Neurasthenia / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy*; D010205:Pantothenic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001736:Biureas; C015979:mebikar; C016030:pantogab; D010205:Pantothenic Acid; D005680:gamma-Aminobutyric Acid